Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000195042 | SCV000246421 | likely benign | not specified | 2015-07-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000341119 | SCV000458284 | uncertain significance | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000527170 | SCV000639572 | benign | Hermansky-Pudlak syndrome 2 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000195042 | SCV000711280 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Phe887Leu in exon 23 of AP3B1: This variant is not expected to have clinical sig nificance because it has been identified in 1.2% (99/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs139344924). |
Johns Hopkins Genomics, |
RCV000527170 | SCV000925948 | benign | Hermansky-Pudlak syndrome 2 | 2019-03-20 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262782 | SCV002542879 | benign | Autoinflammatory syndrome | 2021-02-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001530067 | SCV003916951 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | AP3B1: BP4, BS1, BS2 |
Diagnostic Laboratory, |
RCV001530067 | SCV001744641 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000195042 | SCV001927383 | benign | not specified | no assertion criteria provided | clinical testing |